OTX-14-006: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Dry Eye
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
The objective of the study was to evaluate the efficacy and safety of OTX-DP (dexamethasone
insert) 0.4 mg for intracanalicular use when placed in the canaliculus of the eyelid for the
treatment of the signs and symptoms of dry eye disease